Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers.

Katoh, Yuki; Hara, Hiroyuki; Harada, Tomonori; Hirai, Shuichi

Katoh, Yuki; Hara, Hiroyuki; Harada, Tomonori; Hirai, Shuichi.

Affiliation

Katoh Y; Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, Itabashi-ku, TokyoJapan.
Hara H; Department of Obstetrics and Gynecology, Keio University School of Medicine, Shinjuku-ku, TokyoJapan.
Harada T; Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, Itabashi-ku, TokyoJapan.
Hirai S; Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, Itabashi-ku, TokyoJapan.

Medicine (Baltimore) ; 101(35): e30471, 2022 Sep 02.

Article de En | MEDLINE | ID: mdl-36107519

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: 5-((2-Amino-2-carboxyéthyl)sulfanyl)-3-hydroxy-tyrosine / Mélanome Type d'étude: Diagnostic_studies / Screening_studies Limites: Humans Langue: En Journal: Medicine (Baltimore) Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google